E Janecek

11.6k total citations · 1 hit paper
8 papers, 8.5k citations indexed

About

E Janecek is a scholar working on Geriatrics and Gerontology, General Health Professions and Toxicology. According to data from OpenAlex, E Janecek has authored 8 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Geriatrics and Gerontology, 2 papers in General Health Professions and 2 papers in Toxicology. Recurrent topics in E Janecek's work include Pharmaceutical Practices and Patient Outcomes (4 papers), Epilepsy research and treatment (2 papers) and Opioid Use Disorder Treatment (2 papers). E Janecek is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (4 papers), Epilepsy research and treatment (2 papers) and Opioid Use Disorder Treatment (2 papers). E Janecek collaborates with scholars based in Canada and United States. E Janecek's co-authors include Edward M. Sellers, U. Busto, Inés Ruiz, E A Roberts, C Domecq, Paul Sandor, D J Greenblatt, C. A. Naranjo, Geoffrey Robinson and Anita Srivastava and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and American Journal of Pharmaceutical Education.

In The Last Decade

E Janecek

8 papers receiving 8.0k citations

Hit Papers

A method for estimating the probability of adverse drug r... 1981 2026 1996 2011 1981 2.5k 5.0k 7.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Janecek Canada 5 2.1k 1.5k 1.3k 1.2k 1.1k 8 8.5k
U. Busto Canada 15 2.2k 1.1× 1.5k 1.1× 1.4k 1.1× 1.3k 1.1× 1.2k 1.0× 34 9.0k
Inés Ruiz Chile 10 2.2k 1.0× 1.5k 1.0× 1.3k 1.0× 1.2k 1.0× 1.1k 1.0× 18 8.6k
C. A. Naranjo Canada 19 2.2k 1.1× 1.5k 1.0× 1.3k 1.0× 1.4k 1.1× 1.1k 1.0× 42 9.4k
E A Roberts Canada 19 2.1k 1.0× 1.5k 1.0× 1.3k 1.0× 1.2k 1.0× 1.4k 1.3× 34 9.5k
D J Greenblatt United States 18 2.3k 1.1× 1.6k 1.1× 1.3k 1.0× 1.4k 1.2× 1.2k 1.1× 46 9.5k
C Domecq Canada 3 2.1k 1.0× 1.5k 1.0× 1.4k 1.0× 1.2k 1.0× 1.1k 1.0× 4 8.4k
Judith P. Kelly United States 33 2.2k 1.0× 811 0.6× 378 0.3× 323 0.3× 552 0.5× 66 5.9k
Edeltraut Garbe Germany 45 881 0.4× 679 0.5× 200 0.2× 805 0.7× 804 0.7× 174 6.9k
Susan E. Andrade United States 46 291 0.1× 1.4k 1.0× 364 0.3× 592 0.5× 1.3k 1.2× 103 7.6k
Morten Andersen Denmark 44 351 0.2× 752 0.5× 278 0.2× 756 0.6× 1.1k 1.0× 211 6.6k

Countries citing papers authored by E Janecek

Since Specialization
Citations

This map shows the geographic impact of E Janecek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Janecek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Janecek more than expected).

Fields of papers citing papers by E Janecek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Janecek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Janecek. The network helps show where E Janecek may publish in the future.

Co-authorship network of co-authors of E Janecek

This figure shows the co-authorship network connecting the top 25 collaborators of E Janecek. A scholar is included among the top collaborators of E Janecek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Janecek. E Janecek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kahan, Meldon, et al.. (2011). Pharmacists' experiences with dispensing opioids. Canadian Family Physician. 57(11). 4 indexed citations
2.
Kahan, Meldon, et al.. (2011). Pharmacists' experiences with dispensing opioids: provincial survey.. PubMed. 57(11). e448–54. 21 indexed citations
3.
Busto, Usoa, et al.. (1994). A Problem-Based Learning Course for Pharmacy Students on Alcohol and Psychoactive Substance Abuse Disorders. American Journal of Pharmaceutical Education. 58(1). 55–60. 18 indexed citations
4.
Janecek, E, B.M. Kapur, & P Devenyi. (1987). Oral phenobarbital loading: a safe method of barbiturate and nonbarbiturate hypnosedative withdrawal.. PubMed. 137(5). 410–2. 4 indexed citations
5.
Busto, U., et al.. (1983). An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease.. British Journal of Clinical Pharmacology. 15(4). 451–458. 11 indexed citations
6.
Naranjo, C. A., U. Busto, Edward M. Sellers, et al.. (1981). A method for estimating the probability of adverse drug reactions. Clinical Pharmacology & Therapeutics. 30(2). 239–245. 8382 indexed citations breakdown →
7.
Robinson, Geoffrey, Edward M. Sellers, & E Janecek. (1981). Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique. Clinical Pharmacology & Therapeutics. 30(1). 71–76. 24 indexed citations
8.
Heinz, F, et al.. (1977). [Controlled study of influenza prophylaxis by VUFB amantadin (author's transl)].. PubMed. 26(4). 216–26. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026